@article {686,
	title = {Identification of a second catalytically active trans-sialidase in Trypanosoma brucei.},
	journal = {Biochem Biophys Res Commun},
	volume = {415},
	year = {2011},
	month = {2011 Nov 18},
	pages = {421-5},
	abstract = {The procyclic stage of Trypanosoma brucei is covered by glycosylphosphatidylinositol (GPI)-anchored surface proteins called procyclins. The procyclin GPI anchor contains a side chain of N-acetyllactosamine repeats terminated by sialic acids. Sialic acid modification is mediated by trans-sialidases expressed on the parasite{\textquoteright}s cell surface. Previous studies suggested the presence of more than one active trans-sialidases, but only one has so far been reported. Here we cloned and examined enzyme activities of four additional trans-sialidase homologs, and show that one of them, Tb927.8.7350, encodes another active trans-sialidase, designated as TbSA C2. In an in vitro assay, TbSA C2 utilized α2-3 sialyllactose as a donor, and produced an α2-3-sialylated product, suggesting that it is an α2-3 trans-sialidase. We suggest that TbSA C2 plays a role in the sialic acid modification of the trypanosome cell surface.},
	keywords = {Amino Sugars, Catalysis, Cell Membrane, Cloning, Molecular, Glycoproteins, Glycosylphosphatidylinositols, Mutation, N-Acetylneuraminic Acid, Neuraminidase, Trypanosoma brucei brucei},
	issn = {1090-2104},
	doi = {10.1016/j.bbrc.2011.10.085},
	author = {Nakatani, Fumiki and Morita, Yasu S and Ashida, Hisashi and Nagamune, Kisaburo and Maeda, Yusuke and Kinoshita, Taroh}
}
@article {687,
	title = {Inositol lipid metabolism in mycobacteria: biosynthesis and regulatory mechanisms.},
	journal = {Biochim Biophys Acta},
	volume = {1810},
	year = {2011},
	month = {2011 Jun},
	pages = {630-41},
	abstract = {BACKGROUND: The genus Mycobacterium includes a number of medically important pathogens. The cell walls of these bacteria have many unique features, including the abundance of various inositol lipids, such as phosphatidylinositol mannosides (PIMs), lipomannan (LM), and lipoarabinomannan (LAM). The biosynthesis of these lipids is believed to be prime drug targets, and has been clarified in detail over the past several years.

SCOPE OF REVIEW: Here we summarize our current understanding of the inositol lipid metabolism in mycobacteria. We will highlight unsolved issues and future directions especially in the context of metabolic regulation.

MAJOR CONCLUSIONS: Inositol is a building block of phosphatidylinositol (PI), which is further elaborated to become PIMs, LM and LAM. d-myo-inositol 3-phosphate is an intermediate of the de novo inositol synthesis, but it is also the starting substrate for mycothiol synthesis. Controlling the level of d-myo-inositol 3-phosphate appears to be important for maintaining the steady state levels of mycothiol and inositol lipids. Several additional control mechanisms must exist to control the complex biosynthetic pathways of PI, PIMs, LM and LAM. These may include regulatory proteins such as a lipoprotein LpqW, and spatial separation of enzymes, such as the amphipathic PimA mannosyltransferase and later enzymes in the PIMs/LM biosynthetic pathway. Finally, we discuss mechanisms that underlie control of LM/LAM glycan polymer elongation.

GENERAL SIGNIFICANCE: Mycobacteria have evolved a complex network of inositol metabolism. Clarifying its metabolism will not only provide better understanding of bacterial pathogenesis, but also understanding of the evolution and general functions of inositol lipids in nature.},
	keywords = {Inositol, Lipid Metabolism, Lipids, Models, Biological, Mycobacterium, Phosphatidylinositols},
	issn = {0006-3002},
	doi = {10.1016/j.bbagen.2011.03.017},
	author = {Morita, Yasu S and Fukuda, Takeshi and Sena, Chubert B C and Yamaryo-Botte, Yoshiki and McConville, Malcolm J and Kinoshita, Taroh}
}
@article {694,
	title = {Identification of a novel protein with a role in lipoarabinomannan biosynthesis in mycobacteria.},
	journal = {J Biol Chem},
	volume = {281},
	year = {2006},
	month = {2006 Apr 7},
	pages = {9011-7},
	abstract = {All species of Mycobacteria synthesize distinctive cell walls that are rich in phosphatidylinositol mannosides (PIMs), lipomannan (LM), and lipoarabinomannan (LAM). PIM glycolipids, having 2-4 mannose residues, can either be channeled into polar PIM species (with 6 Man residues) or hypermannosylated to form LM and LAM. In this study, we have identified a Mycobacterium smegmatis gene, termed lpqW, that is required for the conversion of PIMs to LAM and is highly conserved in all mycobacteria. A transposon mutant, Myco481, containing an insertion near the 3{\textquoteright} end of lpqW exhibited altered colony morphology on complex agar medium. This mutant was unstable and was consistently overgrown by a second mutant, represented by Myco481.1, that had normal growth and colony characteristics. Biochemical analysis and metabolic labeling studies showed that Myco481 synthesized the complete spectrum of apolar and polar PIMs but was unable to make LAM. LAM biosynthesis was restored to near wild type levels in Myco481.1. However, this mutant was unable to synthesize the major polar PIM (AcPIM6) and accumulated a smaller intermediate, AcPIM4. Targeted disruption of the lpqW gene and complementation of the initial Myco481 mutant with the wild type gene confirmed that the phenotype of this mutant was due to loss of LpqW. These studies suggest that LpqW has a role in regulating the flux of early PIM intermediates into polar PIM or LAM biosynthesis. They also suggest that AcPIM4 is the likely branch point intermediate in polar PIM and LAM biosynthesis.},
	keywords = {Cell Membrane, Gene Expression Regulation, Bacterial, Genes, Bacterial, Lipopolysaccharides, Mutation, Mycobacterium smegmatis, Phenotype, Phosphatidylinositols, Virulence},
	issn = {0021-9258},
	doi = {10.1074/jbc.M511709200},
	author = {Kovacevic, Svetozar and Anderson, Dianne and Morita, Yasu S and Patterson, John and Haites, Ruth and McMillan, Benjamin N I and Coppel, Ross and McConville, Malcolm J and Billman-Jacobe, Helen}
}
